Buy Semax Online
Semax is a synthetic neuroactive peptide derived from the ACTH(4–10) sequence. It has been researched extensively for its effects on neurological function, neuroprotection, stroke recovery, neurotrophic signaling, and cognitive processes.
Semax is particularly well represented in Russian clinical and experimental literature, where intranasal preparations have been investigated in several neurological settings.
Product Information
Semax is a synthetic peptide containing the ACTH-derived sequence Met-Glu-His-Phe-Pro-Gly-Pro. Unlike conventional stimulants, its research profile centers on neurotrophic and neuroprotective pathways.
Experimental studies have investigated its influence on BDNF and other neurotrophins, neurotransmission, immune signaling, and neuronal responses to ischemic injury.
How Does Semax Work?
Semax appears to influence neurotrophic signaling and neuronal gene expression, including pathways involving BDNF and other neurotrophins. Its complete mechanism has not been fully established.
Semax Benefits
Supports Neuroprotective Research:
Experimental research has found that Semax influences neurotrophin expression and several signaling pathways involved in the brain’s response to ischemic injury. Animal studies have specifically examined changes involving BDNF, NGF, and their receptors.
Research Into Stroke Recovery:
Clinical research has investigated Semax as part of treatment protocols following ischemic stroke. A clinical study involving 30 patients reported effects on the rate of recovery of neurological functions, particularly motor deficits.
Influences BDNF and Neurological Signaling:
More recent clinical research has reported increased plasma BDNF following Semax administration in patients undergoing post-stroke rehabilitation. The study also reported improvements in functional recovery measures, making BDNF-related signaling an important area of Semax research.
Supports Broader Neurological Research:
Semax has also been investigated in conditions involving chronic neurological impairment. A clinical study in patients with motor-neuron disease evaluated intranasal Semax alongside measures of motor function and quality of life.
Semax Side Effects
Published clinical reports generally describe Semax as reasonably well tolerated, although the overall evidence base is smaller than that available for established neurological medications. Reported tolerability findings vary by study and patient population.
Semax Dosage
Published clinical research has used several intranasal dosing protocols.
One clinical study administered a 1% Semax solution intranasally at 12 mg/day in two 10-day treatment courses separated by a two-week break.
A separate ischemic-stroke study reported 12 mg/day for moderate stroke and 18 mg/day for severe stroke, with treatment courses of 5 or 10 days.
These are doses reported in specific clinical research protocols and vary according to the condition being studied.
Research References
Serdiuk AV, Levitskiĭ GN, Miasoedov NF, Skvortsova VI. The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with Semax. Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(4):29–39. PMID: 18379501.
PubMed — Semax 12 mg/day Study
Effectiveness of Semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). PMID: 11517472.
PubMed — Semax Stroke Study
Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of Semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 29798983.
PubMed — Semax and BDNF/Stroke Recovery
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an affiliate-information website and may provide affiliate links to independent third-party suppliers.
The information provided in these pages is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or a recommendation to use any peptide. Research doses are included to describe published study protocols and are not individualized dosing instructions. Product quality, formulation, purity, route of administration, regulatory status, and availability may vary between suppliers and jurisdictions.
